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ABSTRACT AND KEYWORDS 
 
Introduction. International guidelines promote screening by faecal tests in asymptomatic 
people at average-risk of colorectal cancer (CRC) but uptake does not reach 
recommended levels in most countries.   
Objective. The objective of the study was to synthetize evidence on 1) interventions 
aiming to increase uptake of faecal tests for CRC screening, in asymptomatic people at 
average risk of CRC, 2) interventions that targeted general practitioner (GP) involvement 
and 3) interventions that targeted non-responders or disadvantaged groups.  
Methods. Systematic review of randomized controlled trials (RCT), searching Pubmed, 
Embase, and the Cochrane Library database, based on the Cochrane’s PRISMA-P 2015 
guidelines. Risk of bias of included trials was assessed. 
Results. From 24 included RCTs, the following interventions increase uptake of faecal 
tests: advance notification letter (OR 1.20 to 1.51), postal mailing (OR 1.30 to 2.89), 
written reminders (OR 1.31 to 7.70), telephone contacts with an advisor (OR 1.36 to 
7.72). Three interventions demonstrated positive effects of GP involvement such as a GP 
signed invitation letter (OR 1.26), GP communication training (OR 1.22), or mailing 
reminders to GPs (OR 14.8). Inconclusive results were found for studies comparing 
different types of faecal tests, and those testing effectiveness of providing various type of 
written information.  
Conclusion. Advance notification letters, postal mailing of the faecal tests, written 
reminders, and telephone contacts with an advisor increase patient uptake of faecal tests. 
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There was only limited evidence about the effect of GP involvement on screening test 
uptake, and a lack of studies focusing on non-responders or disadvantaged groups. 
 
KEYWORDS 
Colorectal cancer screening, FOBT, patient uptake, primary care, systematic review.  
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INTRODUCTION 
In 2012, colorectal cancer (CRC) was the third most common cancer in men (746,000 
cases) and the second most common in women (614,000 cases); annual mortality exceeds 
500,000 (WHO, 2014). Screening programs conducted by government agencies slightly 
differ from one country to another (Benson et al., 2008; European Colorectal Cancer 
Screening Guidelines Working Group, 2013). However, in most countries, guidelines 
recommend 1) individualized assessment of risk for CRC in all adults, 2) starting 
screening at age 50 and in high-risk adults from 40 years, 3) using stool-based tests, 
flexible sigmoidoscopy, or colonoscopy, but always colonoscopy in high-risk people 
(European Colorectal Cancer Screening Guidelines Working Group, 2013; USPSTF, 
2015). Screening can be stopped in adults over 75 years.  
A minimum uptake is required to ensure screening efficiency, with suggested thresholds  
ranging from 65% to 75% (European Colorectal Cancer Screening Guidelines Working 
Group, 2013; Holme et al., 2013; NCI, 2005). Comparisons between a strategy based on 
colonoscopy and a strategy based on faecal test have shown that adherence was higher 
for screening by faecal test alone (Holme et al., 2013; Inadomi et al., 2012; Khalid-De 
Bakker et al., 2011), suggesting that screening should rely on faecal test completion. 
However participation rates in countries with organized screening programs based on 
faecal tests are low, ranging from 20% to 52%, and with disparities across socio-
economic groups (Gellad et al., 2011).  
In some countries, screening is organized independently of primary care and in others 
such as in France, policymakers decided that general practitioners (GPs) would be the 
only providers of FIT kits (French Ministry of Health, 2014). Factors associated with 
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lower participation rates include: female gender, younger participants, lower level of 
education, lower income, ethnic minorities and being unmarried (Wools et al., 2015). 
Identifying reproducible interventions that may be developed in a wider context is 
essential in order to maximize the efficacy of CRC screening programs. While French 
authorities have decided to organize FIT kit diffusion through GPs, we wondered whether 
there was evidence demonstrating the impact of GP involvement on patient uptake, and 
evidence of interventions that increased patient uptake among disadvantaged or hard-to-
reach groups. Another issue is the need to compile data regarding intervention's costs in 
order to analyse the cost-effectiveness of the corresponding interventions. 
 
The aim of the review was to investigate the following question: what randomized 
controlled trials (RCT) assessed interventions aiming at increasing uptake of faecal tests 
for CRC screening, in asymptomatic subjects at average risk of CRC?  
 
METHOD 
This systematic review was conducted according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2015) 
(Table 1).  
Inclusion and exclusion criteria 
The inclusion criteria for the studies included in this review were:   
 - design: RCT or cluster-RCT,  
- setting: recruitment in a primary care or community setting, or at population level, 
- population: asymptomatic adults at average risk of colorectal cancer. 
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Studies were excluded if: conducted in high-risk patients; targeted to specific patient 
groups (such as army veterans); no specification about participants; not reported in peer-
reviewed publications; non-English or French language. 
 t 
Study identification and selection (Moher et al., 2015) 
We conducted a systematic search of PubMed, Embase, and the Cochrane Central 
Register of Controlled Trials, not limited by dates of publication, on September 1st 2015 
(Text Box 1). We also hand searched reference lists of reviews and studies identified 
during the initial search. Abstracts and full texts were reviewed independently by two 
reviewers (CL and CR) for inclusion. Any disagreements about inclusion or exclusion 
were resolved by consensus and a third reviewer (AE) was consulted to resolve any 
remaining disagreements. When we identified multiple studies from the same authors 
investigating the same population or model, we reported them all as one study.  
 S. 
Data extraction 
One reviewer (CL) extracted data on a form based on the Cochrane data extraction form 
(Cochrane Wounds Group, 2014). Studies were critically appraised by two reviewers (CL 
and CR) using the Cochrane Collaboration’s risk of bias tool (The Cochrane 
Collaboration, 2008), and discrepancies were resolved by consensus. 
Data synthesis and assessment of quality 
We performed narrative data synthesis, organizing the results by intervention in 
accordance with previous presentation from other authors (Senore et al., 2015), 
depending on whether the intervention focused on information to screening invitees, 
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physician practice, or test modalities. Quantitative synthesis was limited by the 
heterogeneity of the study designs and results presentation. In order to ensure consistency 
when reporting the impact of interventions, we re-calculated the number of patients, odds 
ratios, and/or p-values when these data were not provided explicitly in the manuscripts. 
The manuscript authors were contacted when the data provided did not allow 
recalculating OR and/or p-values. For each study, we analyzed the following risks of bias: 
selection bias, performance bias and detection bias, attrition bias, reporting bias. These 
biases were classified in three categories (low, moderate, high), according to the 
PRISMA-P guidelines. We did not assess publication bias. 
 
RESULTS 
In total, 275 titles and abstracts were screened for eligibility utilizing the inclusion and 
exclusion criteria. Twenty-four studies were included in the review (Figure 1). 
The main characteristics of studies are reported in Table 2. The trials varied in their 
design. Three studies targeted the clinician (GPs) for the interventions, and randomised 
by clinician (Aubin-Auger et al., 2014; Federici et al., 2006; Tinmouth et al., 2015). The 
other 21 studies targeted patients directly with the interventions, and randomised by 
patient (Baker et al., 2014; Birkenfeld et al., 2011; Cole et al., 2003, 2007; Federici et 
al., 2005; Gimeno-Garcia et al., 2009; Giorgi Rossi et al., 2011; Green et al., 2013; 
Hewitson et al., 2011; Hol et al., 2010; Hughes et al., 2005; Lee et al., 2009; Levi et al., 
2011; MACS Group, 2006; Mant et al., 1992; Miller et al., 2005; Myers et al., 1991, 
2014; Neter et al., 2014; Ore et al., 2001; Van Roon et al., 2011; Vinker  et al., 2002).  
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The interventions reported in the included studies focused either on the test modalities 
(i.e. FIT vs gFOFT; 6 studies), on patient information (16 studies), or on physician 
practice (2 studies) (Table 3). Ten studies were based on complex interventions ( Baker 
et al., 2014; Cole et al., 2007; Green et al., 2013; Hewitson et al., 2011; Hol et al., 2010; 
Mant et al., 1992; Miller et al., 2005; Myers et al., 1991; Neter et al., 2014; Vinker  et 
al., 2002), which we report across different categories.  
Screening uptakes varied markedly across studies, ranging from 1.2% to 82.2% (Table 
3). In seven studies the uptake in the control group was less than 20%; in 12 studies it 
was from 20-40%; in seven studies it was from 40-60%; and in three it was over 60%. 
Screening uptake assessments were performed after various periods, ranging from 2 
weeks to 24 months (Table 2). In nine studies, screening uptake was assessed before 6 
months; in five studies it was performed between 6 months and one year; and in one it 
was performed at 12 and 24 months. 
Heterogeneous interventions 
FIT vs gFOBT 
Six studies compared the use of FIT vs gFOBT kits (Birkenfeld et al., 2011; Cole et al., 
2003; Federici et al., 2005; Hol et al., 2010; Hughes et al., 2005; Levi et al., 2011). Four 
concluded that using FIT rather than gFOBT significantly increased uptake of screening 
tests (OR from 1.29 to 2.14) (Cole et al., 2003; Federici et al., 2005; Hol et al., 2010; 
Hughes et al., 2005). In contrast, two studies based on large samples (16,132 and 12,537 
people) found gFOBT was associated with higher uptake (OR= 0.86, OR = 0.92) 
(Birkenfeld et al., 2011; Levi et al., 2011).  
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Advanced notification letter 
Two studies reported the positive impact of an advanced notification letter (Cole et al., 
2007; Van Roon et al., 2011). They assessed the impact of mailing an information letter 
before the standard invitation, aiming to raise awareness of CRC screening among 
eligible people (OR ranging from 1.20 to 1.51). A third study also reported higher uptake 
after an advanced notification letter (31.7% vs 25.5%) but the difference was not 
statistically significant (p=0.051) (Mant et al., 1992). 
Postal mailing of kits  
Five studies reported that mailing kits to screening invitees increased uptake (OR ranging 
from 1.30 to 2.89) (Giorgi Rossi et al., 2011; Green et al., 2013; Mant et al., 1992; Ore 
et al., 2001; Tinmouth et al., 2015). Four of these studies compared a direct mailing of 
the kit vs a standard letter with invitation to collect a kit in a primary care clinic (Giorgi 
Rossi et al., 2011; Green et al., 2013; Mant et al., 1992; Ore et al., 2001). The fifth study 
focused on non-respondents to an initial mailed invitation (Tinmouth et al., 2015).  
Frames of invitation messages 
Five studies assessed the effect of different frames of invitation messages (varying 
presentation and content of the written information) (Cole et al., 2007; Hewitson et al., 
2011; MACS Group, 2006; Myers et al., 1991; Neter et al., 2014). Three demonstrated 
increases in uptake, based on a leaflet containing information on FOBT (Hewitson et al., 
2011), an “implementation intention” technique (Neter et al., 2014) or letting the 
participant choose between different screening tests (FOBT, colonoscopy, 
sigmoidoscopy, or CTC) (MACS Group, 2006. Two found no statistically significant 
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effect: one compared gain or loss framed messages in booklets sent with invitation letters 
(Myers et al., 1991); the other evaluated an intervention to enhance awareness of risk of 
CRC based on advocacy messages (Cole et al., 2007).  
Reminders 
Three studies demonstrated increased uptake ranging from 15.6% to 47.1% (OR ranging 
from 1.31 to 7.70), based on telephone and written reminders (Baker et al., 2014; Green 
et al., 2013; Myers et al., 1991).  
Tailored navigation  
Four studies demonstrated increased uptake following a “navigation intervention” based 
on telephone calls by a counselor (OR from 1.36 to 7.72) (Green et al., 2013; Myers et 
al., 1991). In two or three arm RCTs, interventions included: an instruction call to patients 
within a week after kit mailing (telephone call about how to perform the test), a reminder 
phone call at 30 days if no tests were returned (Myers et al., 1991); telephone assistance 
with a navigator after postal mailing of kits and mailed reminder letters (Baker et al., 
2014; Green et al., 2013); personal navigator call to review mailed materials and explore 
preferences and barriers for screening (Myers et al., 2014).  
Video-based or computer-based interventions 
Two studies assessed video-based or computer-based interventions. One reported a slight 
improvement of test uptake within 2 weeks after a video-based educational intervention 
(69.9% vs 54.4%, p = 0.044) (38). The second compared the effect of counseling provided 
by automatized informatics software to counseling by a nurse (Miller et al., 2005), 
without showing any impact on uptake of screening tests (62% vs 63%).  
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Improving GP involvement 
Finally, three studies reported interventions requiring GP involvement. Two showed 
increased uptake – from 12.2% to 15.3% (each statistically significant) (Aubin-Auger et 
al., 2014; Vinker et al., 2002) – while one was inconclusive (Hewitson et al., 2011). 
Aubin-Auger (2014) reported the impact of GP training focused on communication skills 
(increased screening uptake in the intervention arm (36.7% vs 24.5%; p = 0.03). Vinker 
(2002) demonstrated the impact of mailing reminders to GPs, rather than sending 
reminders to screening participants (OR = 14.8).  
Focus on non-responders and disadvantaged groups 
One study focused on non-responders (Tinmouth et al., 2015). Six authors reported that 
a higher socioeconomic status was associated with a higher uptake of screening test 
(Birkenfeld et al., 2011; Cole et al., 2003; Hol et al., 2010; Levi et al., 2011; Neter et al., 
2014; Van Roon et al., 2011). However, none of them reported a specific impact of the 
experimented intervention on screening uptake inequalities in the corresponding 
populations. None of the studies assessed targeted interventions aiming to improve 
participation in disadvantaged groups.  
Focus on intervention costs 
Costs related to the intervention were reported in 4 studies, but there were wide variations 
in the data provided. Giorgi Rossi et al. (2011) assessed the cost of mailing FOBT (from 
4.24 euros to 46.80, depending on whether the patient was a responder or not). The cost 
of performing a standard recall ranged from 3.29 to 18.30 (depending on whether the 
patient was a responder or not). Baker et al. (2014) evaluated the cost per completed test 
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at $43.13, based on a complex intervention with mailing, automated call, and text 
message. Green et al. (2013) reported costs ranging from $371 to $557 for interventions 
based on assisted care or navigated group. 
 
DISCUSSION 
Principal findings  
From 24 randomized controlled studies, the following interventions increased uptake of 
faecal tests for CRC screening: advance notification letter (Cole et al., 2007; Van Roon 
et al., 2011), postal mailing (Giorgi Rossi et al., 2011; Green et al., 2013; Mant et al., 
1992; Ore et al., 2001; Tinmouth et al., 2015), written reminders (MACS Group, 2006; 
Myers et al., 1991), telephone contacts with a navigator or a medical assistant (Baker et 
al., 2014; Green et al., 2013; Myers et al., 1991, 2014). Three interventions demonstrated 
positive effects of GP involvement (Aubin-Auger et al., 2014; Hewitson et al., 2011; 
Vinker et al., 2002) using a GP signed invitation letter, GP communication training or 
mailed reminders to GPs. Other studies assessed whether patient counseling could be 
provided by video or using automatized informatics software (Gimeno-Garcia et al., 
2009; Miller et al., 2005). Inconclusive results were found for studies comparing FIT vs 
FOBT, and those testing effectiveness of different formats of written information. None 
of the interventions targeted participation in disadvantaged groups. Only one focused on 
non-responders (Tinmouth et al., 2015).  
Strengths and weaknesses  
Quality of the evidence  
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General evaluation showed risks of bias for most studies. None of the studies was blinded. 
Loss-to-follow-up and randomization were frequently unclear – reported in only eight 
studies (Aubin-Auger et al., 2014; Green et al., 2013; Lee et al., 2009; Levi et al., 2011; 
MACS Group, 2006; Miller et al., 2005; Ore et al., 2001; Van Roon et al., 2011). Only 
nine studies reported a power calculation (Aubin-Auger et al., 2014; Cole et al., 2003; 
Federici et al., 2006; Gimeno-Garcia et al., 2009; Hewitson et al., 2011; Hol et al., 2010; 
MACS Group, 2006; Miller et al., 2005; Van Roon et al., 2011). Selective reporting was 
estimated as moderate or high risk for 6 studies (Birkenfeld et al., 2011; Cole et al., 2007; 
Gimeno-Garcia et al., 2009; Mant et al., 1992; Ore et al., 2001; Vinker  et al., 2002). 
Funding source was missing in 8 studies (Baker et al., 2014; Birkenfeld et al., 2011; 
Federici et al., 2005; Hewitson et al., 2011; Levi et al., 2011; Mant et al., 1992; Myers et 
al., 1991; Neter et al., 2014).  
Most studies focused on an average-risk population aged from 50 to 74. Five studies 
included populations defined by other age thresholds (Cole et al., 2007; Hewitson et al., 
2011; Lee et al., 2009; MACS Group, 2006; Mant et al., 1992) -such as 45-64 years (Mant 
et al., 1992) or 60-75 years (Lee et al., 2009)- but the related reasons were not provided.  
Potential biases in the review process  
Grey literature was not searched, potentially leading to publication bias. Interventions 
leading to null results are less likely to have been accepted for publication so the review 
may over-estimate apparent intervention effects.  
Comparison with other studies 
From observational studies, Vart et al. (2014) reported FIT characteristics that might 
improve CRC screening uptake: simplicity of tests, absence of dietary restrictions, less 
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stool manipulation and simplified procedures for analysis. Their meta-analysis also 
supported higher uptake rates in the FIT group. Both Vart’s and our review found greater 
uptake with FIT tests for studies in the earlier period (2003-2010). However these results 
were not confirmed by the two most recent studies performed with larger samples 
(Birkenfeld et al., 2011; Levi et al., 2011). The conflicting results may reflect that the 
first studies were performed in people who were asked to make dietary restrictions before 
the test, but dietary restrictions were not requested in the two later studies. Concerning 
stool DNA tests, previous authors reported that patients would prefer DNA test to 
colonoscopy (Cole et al., 2015; Abola et al., 2015) but we did not find studies comparing 
FIT and DNA tests and focusing on test uptake. A recent publication from Berger et al. 
(2016) reported an excellent participation rate with stool DNA tests (99%) but they did 
not discuss the selection bias.  
This review provides evidence that various interventions increase test uptake and could 
be easily implemented: advance notification letter, postal mailing of screening tests, and 
written reminders. These results are consistent with the findings of previous reviews that 
included RCTs, but also observational, cross-sectional, experimental, and before and after 
studies (Camilloni et al., 2013; Sabatino et al., 2008; Senore et al., 2015). Camilloni et 
al. (2013) also concluded that postal and telephone reminders, mailed invitation letters 
signed by GPs, scheduled appointments and mailing kits to non-responders were effective 
interventions. Sabatino et al. (2008) reviewed 11 interventions to increase screening for 
cervical, breast and colon cancers. They reported that one-to-one education and reminders 
improve uptake rates for CRC screening tests.  
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Telephone contacts and involvement of navigators also led to higher uptake of screening 
tests, but these are more resource-intensive and may be difficult to implement in the usual 
screening setting. These results are consistent with the conclusions of Naylor et al. (2012) 
who focused on interventions that decrease racial and ethnic disparities toward CRC care 
and prevention. Naylor included 33 studies targeting African-American, Hispanic, and 
other minorities’ individuals. Navigation interventions – including specific elements such 
as language-adapted education materials in complex interventions – increased CRC 
screening uptake in these specific populations. However, all these interventions require 
recruiting navigators, training and making them available in the routine healthcare setting, 
and there is limited generalizable evidence for the whole population at average risk of 
colorectal cancer (Senore et al., 2015). Moreover, our focus on the costs associated with 
such interventions show that they would be associated with a multiplication of the costs 
(from 4€ to 500€ / completed test).  
Further interventions could involve video or computer-based information. However, such 
information modalities might not be sufficient to convince people who are not concerned 
about colorectal cancer risk to consider screening. The positive effect observed for these 
interventions might also be due to a selection bias (see table 2).  
There was limited evidence that training GPs is effective. Senore et al. (2015) suggested 
that giving feedback to providers about their screening rates may reinforce their 
commitment to promote screening. However, the original research leading to this 
statement was a “before vs after” study performed among resident physicians from 1993 
to 1995 (Goebel et al, 1997), so that further research would be required in order to 
generalize these findings to private practice or other settings. Developing specific 
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communication skills may also be effective, but implementing changes in every day 
practice after formal continuing medical education is difficult. Concerning 
communication-based interventions direct to patients, they can be effective for chronic 
disease management, but there are difficulties in modifying preventive behaviors 
(Mehring et al., 2014; Hilberink et al., 2011; Butler et al., 2013). It may be hypothesized 
that general practitioners could enhance screening uptake, utilizing their long-term 
relationships with patients. However, there is a lack of well-designed trials involving GPs, 
while such studies could focus on barriers to test uptake.    
The US guidelines promote letting patients choose between various screening strategies: 
faecal tests, colonoscopy, flexible sigmoidoscopy, or computed tomography 
colonography (USPSTF, 2016). However, various authors reported that screening uptake 
was lower with colonoscopy than with FIT (Segnan et al., 2007; Quintero et al., 2012; 
Inadomi et al., 2012). Recent publications suggested that patients might prefer computed 
tomography colonography (Gareen et al., 2015; Pooler et al., 2012). However, there is 
no evidence that one strategy would lead to better uptake (Ghanouni et al., 2014). 
Comparing test uptake is difficult because recommended intervals between tests are very 
different, depending on the test itself (Levin et al., 2008; Rex et al., 2009). Holme et al. 
(2013) aimed at providing data on flexible sigmoidoscopy attendance: on the population 
level, attendance rates were estimated at 38% and 10% in two studies (Atkin et al., 2010; 
Segnan et al., 2005), while it was only estimated between 0.3% and 3.4% in the third one 
(Simpson et al., 2000). In total, MACS et al. (2006,b) et Senore et al. (2015) concluded 
that offering people the option to choose between flexible sigmoidoscopy and FIT did not 
improve uptake.  
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Conclusion  
Advance notification letters, postal mailing of the kits, written reminders, and telephone 
contacts with an advisor increase patient uptake of faecal tests. There is limited evidence 
about the effect of GP involvement on screening test uptake, and a lack of studies focusing 
on non-responders or disadvantaged groups.  
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Table 1. PICO determinants of our review 
 
Population Intervention Comparison Outcomes Study design 
Asymptomatic people at 
average risk of colorectal 
cancer 
All interventions aiming to 
increase faecal test uptake 
Intervention vs 
control group 
Screening test uptake. 
Number of screened cancers 
Randomized 
controlled trials 
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Table 2. Studies description 
Author, year, setting Sample Design 
Duration to 
assess 
uptake 
Intervention 
Risk of bias 
     
Selection 
bias 
Performance and 
detection bias 
Attrition 
bias 
Reporting 
bias 
Aubin-Auger, 2015, France 45 GPs1 
Cluster 
RCT2 
7 months 
Implementation of a training course focused on 
communication skills among GPs 
low low low low 
Baker, 2014, USA 450 RCT 6 months 
1: Mailing an FIT3 kit.  
2: Telephone and text reminders.  
3: For non-respondents within 3 months, personal 
navigator contact 
moderate low moderate Low 
Myers, 2014, USA 764 RCT 6 months 
Preference-based tailored navigation on CRC 
screening4 
low moderate low low 
Neter, 2014, Israel 29 833 RCT 
2 and 6 
months 
Use of the II (implementation intentions). 1: 
instruction leaflet sent to participants. 2: the leaflet 
contained suggestions for overcoming common 
problems that individuals face in attempting to 
perform FOBT, and an encouragement 
moderate high moderate Low 
Tinmouth, 2014, Canada 3 594 RCT 6 months Addition of a gFOBT kit to a second mailed invitation moderate moderate low low 
Green, 2013, USA 4 675 
4 arms 
RCT 
12 and 24 
months 
Use of a stepped-intensity intervention.  
1: usual care: information letter and FOBT kit mailing. 
2: automated care: in addition, a study database 
registry tracked when screening was due and 
Low moderate low low 
                                                           
1 GPs: General Practioners 
2 RCT : Randomized Controlled Trial 
3 FIT : Faecal Immunological Test 
4 CRC : Colorectal Cancer 
29 
 
29 
 
automatically generated mailings. Non-respondents 
received a reminder letter.  
3: assisted care: in addition, telephone assistance 
from a MA to complete screening.  
4: navigated care: in addition, support from a nurse on 
questions or requests for an FOBT alternative. Medical 
assitants contacted navigated patients who did not 
request such alternative. 
Birkenfled, 2011, Israel 16 132 RCT - Use of FIT Low Moderate Moderate Moderate 
Hewitson, 2011, UK 1 288 
4 arms 
RCT 
20 weeks 
Use of educational letters.  
1 :GP's endorsement letter,  
2:  enhanced procedural instruction leaflet.  
3: GP's letter plus leaflet,  
4: control. An FOBT kit was sent a week after the first 
mailed letter. 
Low Moderate Moderate Low 
Levi, 2011, Israel 12 537 RCT - Use of FIT Moderate Moderate Moderate Low 
Giorgi Rossi, 2011, Italy 4 219 RCT 9 months Direct kit-mailing Low Moderate Low Low 
Van Roon, 2011, 
Netherlands 
5 000 RCT 8 months Use of a mailed advanced notification letter 
Low Moderate Low Low 
Gimeno-Garcia, 2009, Spain 158 RCT 12 months Video-based educational intervention moderate Moderate Moderate High 
Lee, 2009, USA 775 RCT 6 months Use of a mailed educational reminder Low Low Low Low 
Hol, 2009, Netherlands 15 011 RCT 12 months Use of FIT, and patient mailed reminders Low Moderate Low Low 
Cole, 2007, Australia 2 400 
4 arms 
RCT 
2 weeks 
Use of 3 different mailed information: risk, advocacy, 
advanced notification 
Moderate Moderate High Moderate 
MACS group, 2006, Australia 1 333 RCT - 
Use of choice between different screening tests (FIT, 
colonoscopy, Flexible sigmoidoscopy plus FIT) 
low moderate low Low 
Cole, 2003, Australia 1 818 RCT - 
Use of FIT with spatula and FIT with brush (a more 
simple stool sample) 
low moderate moderate Low 
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Hughes, 2005, Australia 3 358 RCT - Use of FIT moderate moderate moderate Low 
Federici, 2005, Italy 7 332 
Cluster 
RCT 
- Use of FIT 
moderate moderate moderate Low 
Miller, 2005, USA 204 RCT 1 month 
Use of a computer-assisted intervention and a nurse 
counseling intervention 
low low low Low 
Vinker, 2002, Israel 2 315 
4 arms 
RCT 
- 
1: use of a reminder note to the physician.  
2: patients received either a reminder letter or a 
phone call. One month later the non-responders 
received a follow-up reminder using the same method 
(the 4th arm if a control group) 
moderate moderate high High 
Ore, 2001, Israel 2 000 RCT 5 months Direct kit-mailing moderate moderate low High 
Mant, 1992, UK 1 588 
4 arms 
RCT 
- 
1: mailed kit.  
2: mailed kit with an invitation for a health check.  
3: invitation for a health check, test offered at the 
health check.  
4: just invited for the health check. 
moderate moderate high High 
Myers, 1991 2 201 RCT 3 months 
Use of a booklet, telephone reminders and health 
education messages framed in "loss" terms as 
compared to those framed in "gain" terms. 
moderate moderate high Low 
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Table 3. Interventions and their related impact on patient uptake of screening tests 
 
Intervention and control Uptake of test OR p 
Use of FIT vs Gfobt 
Cole 2003 FIT with a spatula  39.6% vs 23.4% 2.14 [1.66-2.77] <0.001 
 FIT with a brush 30.5% vs 23.4% 1.44 [1.10-1.87] 0.007 
Hughes  FIT 38.7% vs 30.2% 1.93 [1.61-2.31] <0.001 
Federici FIT 36.1% vs 30.4% 1.29 [1.17-1.43] <0.001 
Hol Mailed FIT and reminders 61.5% vs 49.5% 1.63 [1.5-1.77]  <0.001 
Birkenfeld FIT vs FOBT 23.1% vs 24.6% 0.92 [0.85-0.99] 0.036 
Levi  FIT vs FOBT 25.9% vs 28.8% 0.86 [0.80-0.94] <0.001 
Advanced notification letter 
Van Roon  57.8% vs 51.5% 1.20 [1.07-1.34] <0.001 
Cole  25.2% vs 18.2% 1.51 [1.13-2.02] 0.004 
Mant (1992)  31.7% vs 25.5% 1.35 [0.99-1.87] 0.051 
Postal mailing of FOBT kits 
Mant  25.5% vs 20.6% 1.31 [0.98-1.85] 0.112 
Ore  19.9% vs 15.9% 1.31 [1.04-1.67] 0.021 
Giorgi Rossi  14.6% vs 10.7% 1.42 [1.18-1.71] <0.001 
Giorgi Rossi  63.0% vs 56.8% 1.30 [1.12-1.5] <0.001 
Green   50.8% vs 26.3% 2.89 [2.42-3.45] <0.001 
Tinmouth  20.1% vs 9.6% 2.35 [1.93-2.90] <0.001 
Presentation and content of written information 
Myers Loss vs gain framed message 36% vs 40% 0.87 [0.73-1.03] 0.10 
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MACS group Shared decision making 27.4% vs 18.6% 1.65 [1.04-2.64] 0.027 
Cole Advocacy messages, or messages 
focusing on risk  
40.3% vs 36% 1.20 [0.95-1.53] 0.14 
Hewitson  Enhanced procedural information 
leaflet  
58.2% vs 52.2% 1.26 [1.01-1.58] 0.044 
Neter  Implementation intention technique 71.4% vs 67.9% 1.18 [1.12-1.24] <0.001 
Written and telephone reminders 
Lee Educational patient reminder by post 64.6% vs 48.4% 1.94 [1.45-2.60] <0.001 
Green Mailed reminder letters 57.5% vs 50.8% 1.31 [1.11-1.55] 0.001 
Baker  Telephone and text message 
reminders  
73.8% vs 26.7% 7.70 [4.98-
12.03] 
<0.001 
Telephone contacts with a navigator, medical assistant or nurse 
Myers  Instruction call  48% vs 37% 1.57 [1.27-1.92] <0.001 
Green  Telephone assistance 64.7% vs 57.5% 1.36 [1.14-1.61] <0.001 
Baker  Phone contact with a personal 
navigator for non-compliant patients 
82.2% vs 37.3% 7.72 [4.91-12.3] <0.001 
Myers  Telephone contact with a navigator 21.5% vs 15.3% 1.51 [1.03-2.24] 0.031 
Videos and computers 
Gimeno-Garcia Video-based educational intervention 69.9% vs 54.4% 1.91 [0.95-3.89] 0.07 
Miller  Counseling provided by automatized 
informatics software 
62% vs 63% 0.96 [0.51-1.79] 1 
Intervention requiring GP involvement 
Hewitson GP-signed invitation letter 58.1% vs 52.3% 1.26 [1.01-1.58] 0.044 
Aubin-Auger  GP training focused on 
communication skills 
36.7% vs 24.5% 1.22 [1.07-1.41] 0.003 
Vinker Reminder sent to GPs 16.5% vs 1.2% 14.8 [8.1-29.6] <0.001 
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FIGURE LEGENDS 
. Text Box 1. Search algorithms. 
. Figure 1. Flowchart of studies identification in this systematic review of RCT, assessing 
intervention to increase uptake to colorectal screening. 
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Text Box 1. Search algorithms. 
MEDLINE algorithm 
Filters: Clinical Trial; Randomized Controlled Trial; Review; English; French ; ((("Patient Compliance"[Mesh]) OR 
"Patient Participation"[Mesh])) AND ((("Mass Screening"[Mesh] OR "Early Detection of Cancer"[Mesh])) AND 
colorectal cancer) ; Filters: Clinical Trial; Randomized Controlled Trial; Review; English; French 
EMBASE algorithm 
'patient compliance'/exp OR 'patient participation'/exp AND ('mass screening'/exp OR 'early diagnosis'/exp) 
AND 'colorectal cancer'/exp AND ('review]' OR 'clinical trial') AND ([english]/lim OR [french]/lim) 
COCHRANE LIBRARY 
systematic review of the CRC group publications 
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Figure 1. Flowchart of studies identification in this systematic review of RCT, assessing 
intervention to increase colorectal screening uptake. 
 
 
 
 
 
Medline n=183 Embase n=92 
Analysis based on 
title and abstracts 
n=275 
Full text analysis 
 n=55 
Excluded n=220 
Excluded n=31 
 
No data in the abstract (n= 23)  
Non RCT (n= 8) 
Protocol (n= 10) 
No screening stage (n=28) 
No intervention (n=78) 
Colonoscopy program (n=48) 
 No participation data (n=12) 
 No average-risk population (n=13) 
Excluded = 31 
 
. No average-risk population (n=13)  
. Colonoscopy (n=9)  
. Review (n=1)  
. Poor methodology (n=7)  
. Non interventional study (n=1) 
Included studies 
n=24 
